期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肿瘤血管生成及其影像的研究进展 被引量：2

暂未订购
导出
摘要 综述了肿瘤血管生成的分子病理学和影像学手段在监控肿瘤血管生成方面的研究现状和进展,讨论了影像学目前存在的缺陷和不足,并提出了可能的发展方向。
作者 姜庆军 李慎江 刘士远 肖湘生
机构地区 第二军医大学长征医院影像科
出处 《国外医学（临床放射学分册）》 2002年第5期259-262,共4页
关键词 肿瘤血管生成 研究进展 新生血管化 磁共振成像 超声检查 X线计算机体层摄影术 分子病理学
分类号 R730.23 [医药卫生—肿瘤]
  • 相关文献

参考文献23

  • 1William W, Li P. Tumor angiogenesis molecular pathology therapeutic targeting, and imaging. Acad Radiol, 2000, 7: 800-811
  • 2Robert C, King C, Li P. In vivo monitoring of tumor angiogensis with MR imaging. Acad Radiol, 2000, 7:812-823
  • 3Katherine W, Christopher RB,Peter N, et al. Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. Acad Radiol, 2000, 7: 824-839
  • 4Hawighorst H, Knapstein PG, Knop MV, et al. Cervical carcinoma: standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. MAGMA, 1999, 8(1): 55-62
  • 5Mayr NA, Hawighorst H. MR microcirculation assessment in cervical cancer: correlation with histomorphological tumor markers and clinical outcome. J Magn Reson Imaging, 1999, 10(3): 267-276
  • 6Bone B, Aspelin P, Bronge L, et al. Contrast-enhanced MR imaging as a prognostic indicator of breast cancer. Acta Radiol 1998, 39(3): 279-284
  • 7Furuta A, Ishibashi T. Magnetic resonance imaging of breast cancer: correlation between contrast enhancement and tumor angiogenesis. Nippon Igaku Hoshasen Gakkai Zasshi, 1999, 59(12): 682-688
  • 8Tynninen O, Aronen HJ, Ruhala M, et al. MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation. Invest Radiol, 1999, 34(6): 427-434
  • 9Yasumura K, Ogawa K, Yuasa Y, et al. Dynamic MRI and tumor angiogenesis of breast cancer. Nippon Igaku Hoshasen Gakkai Zasshi, 2000, 60(7): 379-388
  • 10Sipkins DA, Cheresh DA, Kazemi MR, et al. Detection of tumor angiogenesis in vivo by alpha Vbeta3-targeted magnetic resonance imaging. Nat Med, 1998, 4(5): 623-626

同被引文献41

  • 1Von-Marschall Z,Cramer T, Hocker M, et al. Dual Mechanism of VEGF Upregulation by Hypoxia in Human Hcc[M]. Gut, 2001,48(1):87-96.
  • 2Kim Y-B, Park YN, Park C. Increased Proliferation Activities of Vascular Endothelial Cells and Tumor Cells in Residual Hepatocellular Carcinoma Following Transcatheter Arterial Embolization[J]. Histopathology, 2001,38(2):160-166.
  • 3Wild R, Ramakrishnan S, Sedgewiek J, et al. Quantitative Assessment of Angiogenesis and Tumor Vessel Arehheeture by Computer-Assisted Digital Image Analysis:Effects of VEGF Toxin Conjugate on Tumor MVD[J]. Microvasc Res,2000,59(3):368.
  • 4Benjamin LE, Golijanin D, Itin A, et al. Selective Ablation of Immature Blood Vessels in Established Human Tumors Follows VEGF Withdrawal[J]. J clin Invest, 1999,103(2):159-165.
  • 5Gunga HC,Kirsh K,Rocker L,et al. VEGF in Exercising Humans under Different Environmental Conditions[J]. Eur J Appl physiol,1999,79(6):484-490.
  • 6Norio H, Hisashi T, Mitsuo T, et al. Hepatocyte Growth Factor Promotes Hepatocarcinogenesis Through c-Met Autocrine Activation and Enhanced Angiogenesis in Transgenic Mice Treated with Diethylnitrosamine[J]. Oncogene, 2002,21(12):1791.
  • 7Gale NW,Yancopoulos GD. Growth Factors Acting via Endothelial Cell-Specific Receptor Tyrosine Kinases: VEGFs, Angiopoietins,and Ephrins in Vascular Development [J]. Genes Dev, 1999,13(7):1055-1066.
  • 8Ferrara N,Alitalo K. Clinical Applications of Angiogenic Growth Factors and their Inhibitors[J]. Nat Med,1999,5(6):1359-1364.
  • 9Holash J, Maisonpierre PC, Compton D, et al. Vessel Cooption,Regression,and growth in Tumors Mediated by Angiopoietins and VEGF[J]. Science, 1999,284(5922):1994-1998.
  • 10Nor JE, Christensen J, Moony DJ, et al. VEGF-Mediated Angiogenesis is Associated with Enhanced Endothelial Cell Survival and Induction of Bcl-2 Expression[J]. Am J Pathol, 1999,154(2):375-384.

引证文献2

二级引证文献3

国外医学（临床放射学分册）
2002年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部